Interestingly, we found that co-expression of CDs160/CD200 was found in 90% of CLL and in 60% of HCL compared to 40% of other B-NHL patients; moreover, 24% of B-NHL patients showed double negative expression of both markers. Here, CD200 is linked to B-cell chronic lymphocytic leukemia.